Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Platelet- Derived Growth Factor Receptor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- PDGF α receptor is a mediator for Cisplatin-induced Met expression.
- B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant d…
- Indispensable functions of ABL and PDGF receptor kinases in epithelial adherence of attaching/effaci…
- Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
- Radiation-induced effects on TGF-β and PDGF receptor signaling in cancer-associated fibroblasts.
Most Relevant Clinical Trials
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacet…
- Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiform…
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
- Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With S…
- Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harbori…
